Form 4 for TMDX TransMedics Group, Inc.
Accepted 2025-02-26 00:00:00 ET · period of report 2025-02-24 · accession 0000950170-25-028040 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-26 | 2025-02-24 | TMDX | Khayal Tamer I | Chief Commercial Off | A - Grant | $0.00 | +17.6K | 38.4K | +84% | $0 |
| D | 2025-02-26 | 2025-02-24 | TMDX | Khayal Tamer I | Chief Commercial Off | A - Grant | $0.00 | +26.5K | 26.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-24 | A | A | 17,606 | $0.00 | 38,449 | D | — | — | (F1) Consists of 17,606 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-02-24 | A | A | 26,499 | $0.00 | 26,499 | D | $77.12 · — to 2035-02-24 | 26,499 Common Stock | (F2) The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 24, 2025 until the option is fully vested on February 24, 2029, subject to continued service. |